Vanguard Group Inc. Has $629.92 Million Holdings in Chemed Corporation $CHE

Vanguard Group Inc. cut its holdings in Chemed Corporation (NYSE:CHE) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,472,254 shares of the company’s stock after selling 66,233 shares during the period. Vanguard Group Inc. owned about 0.10% of Chemed worth $629,919,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CHE. Smartleaf Asset Management LLC increased its holdings in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the last quarter. First Horizon Corp acquired a new position in shares of Chemed in the third quarter valued at $31,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Chemed in the third quarter valued at about $45,000. Geneos Wealth Management Inc. boosted its position in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the period. Finally, Employees Retirement System of Texas bought a new stake in shares of Chemed in the third quarter valued at about $64,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CHE has been the subject of several recent analyst reports. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Royal Bank Of Canada increased their target price on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Finally, Oppenheimer decreased their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $501.50.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.33% of the company’s stock.

Chemed Stock Performance

Shares of CHE stock opened at $421.65 on Monday. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $583.96. The firm has a 50 day moving average of $399.29 and a 200-day moving average of $425.94. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The company has a market cap of $5.60 billion, a price-to-earnings ratio of 22.98, a price-to-earnings-growth ratio of 1.58 and a beta of 0.54.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same period last year, the business earned $5.63 EPS. Chemed’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts forecast that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date was Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 13.08%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.